ICN1 increased molecularly defined myf5-GFP+/mylz2-negative TPCs 3-fold when compared with tumors that express only kRASG12D, yet ICN1-expressing ERMS cells had a 23-fold increase in TPCs when assessed by limiting dilution cell transplantation. Here, MYF5 is linked to embryonal rhabdomyosarcoma.